Diabetic Nephropathy Type 2 Clinical Trial
Official title:
Association of Serum N/OFQ, IL-6 and IL-6 Gene Polymorphisms With Type 2 Diabetic Nephropathy
At present, the early diagnosis ability of diabetic nephropathy (DKD) is relatively poor, leading to some missed diagnosis of early disease patients. At the same time, because DKD patients have complex metabolic disorders, once they develop to end-stage renal disease, compared with other renal diseases, the treatment of DKD is more difficult and the prognosis is poor. At present, the main treatment for DKD is to strengthen blood glucose control and control blood pressure through renin angiotensin aldosterone system (RAAS) to delay the occurrence and development of DKD, but it can not reduce the risk of most patients progressing to end-stage renal disease (ESRD). In recent years, it is becoming a new therapeutic target for DKD to control the inflammatory response by targeting the inflammatory factors and inflammatory signaling pathways. Therefore, this study attempts to explore the correlation between N / OFQ and the occurrence and development of type 2 DKD, and seek new theoretical basis for the potential treatment of inflammation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03840343 -
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
|
Phase 1 | |
| Completed |
NCT04549324 -
Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
|
||
| Recruiting |
NCT03502031 -
Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
|
Phase 4 | |
| Completed |
NCT03681704 -
the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD
|
Phase 1 | |
| Completed |
NCT03681249 -
the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD
|
Early Phase 1 | |
| Withdrawn |
NCT03504566 -
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
|
Phase 4 | |
| Completed |
NCT03889236 -
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
|
N/A | |
| Completed |
NCT06326034 -
Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
|
Phase 4 | |
| Recruiting |
NCT04931537 -
Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
|
||
| Not yet recruiting |
NCT05373004 -
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03622762 -
Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy
|
Phase 2 | |
| Recruiting |
NCT03445247 -
Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy
|
N/A | |
| Not yet recruiting |
NCT06068439 -
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05487755 -
Investigational and Comparative Study in the Management of Diabetic Nephropathy
|
Phase 3 | |
| Recruiting |
NCT04143412 -
Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
|
Phase 2 | |
| Not yet recruiting |
NCT06222476 -
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
|
N/A | |
| Active, not recruiting |
NCT04573920 -
Atrasentan in Patients With Proteinuric Glomerular Diseases
|
Phase 2 | |
| Recruiting |
NCT05888909 -
Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
|
||
| Not yet recruiting |
NCT03591939 -
T-regulatory Cells in Diabetic Type Two Nephropathy
|
||
| Active, not recruiting |
NCT03859817 -
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
|